Clara Vinas
Overview
Explore the profile of Clara Vinas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
186
Citations
1065
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Noori Z, Sola M, Vinas C, Teixidor F, Poater J
Beilstein J Org Chem
. 2025 Feb;
21:412-420.
PMID: 39996167
A new series of -carborane-fused pyrazoles has been recently successfully synthesized. This fusion was expected to create a hybrid 3D/2D aromatic system, combining the 3D aromaticity of -carborane with the...
2.
Belchior A, Alves B, Mendes E, Megre F, Alves L, Santos P, et al.
EJNMMI Res
. 2025 Feb;
15(1):13.
PMID: 39982528
Background: Protons, which are considered low-LET (Linear Energy Transfer) radiation, have an average RBE (relative biological effectiveness) of 1.1, with a range from 0.7 to 1.6. Thus, increasing biological effectiveness...
3.
Poater J, Escayola S, Poater A, Teixidor F, Ottosson H, Vinas C, et al.
J Am Chem Soc
. 2025 Jan;
147(3):2914.
PMID: 39780609
No abstract available.
4.
Palmieri M, Monti Hughes A, Trivillin V, Garabalino M, Ramos P, Thorp S, et al.
Pharmaceuticals (Basel)
. 2024 Oct;
17(10).
PMID: 39459007
Background: Boron neutron capture therapy (BNCT) is a tumor-selective particle radiotherapy that combines preferential boron accumulation in tumors and neutron irradiation. Based on previous studies in tumor-bearing mice, this study...
5.
Gutierrez-Galvez L, Garcia-Mendiola T, Lorenzo E, Nuez-Martinez M, Ocal C, Yan S, et al.
J Mater Chem B
. 2024 Aug;
12(38):9550-9565.
PMID: 39141010
Anticancer drugs inhibit DNA replication by intercalating between DNA base pairs, forming covalent bonds with nucleotide bases, or binding to the DNA groove. To develop safer drugs, novel molecular structures...
6.
Justin Grams R, Santos W, Scorei I, Abad-Garcia A, Rosenblum C, Bita A, et al.
Chem Rev
. 2024 May;
124(11):7531.
PMID: 38805669
No abstract available.
7.
Guerrero I, Vinas C, Teixidor F, Romero I
Molecules
. 2024 May;
29(10).
PMID: 38792238
A new cooperative photoredox catalytic system, [Ru(trpy)(bpy)(HO)][3,3'-Co(8,9,12-Cl-1,2-CBH)], , has been synthesized and fully characterized for the first time. In this system, the photoredox catalyst [3,3'-Co(8,9,12-Cl-1,2-CBH)], a metallacarborane, and the oxidation...
8.
Justin Grams R, Santos W, Scorei I, Abad-Garcia A, Rosenblum C, Bita A, et al.
Chem Rev
. 2024 Feb;
124(5):2441-2511.
PMID: 38382032
Boron-containing compounds (BCC) have emerged as important pharmacophores. To date, five BCC drugs (including boronic acids and boroles) have been approved by the FDA for the treatment of cancer, infections,...
9.
Affes S, Stamatelou A, Fontrodona X, Kabadou A, Vinas C, Teixidor F, et al.
ACS Appl Mater Interfaces
. 2023 Dec;
16(1):507-519.
PMID: 38114421
A ruthenium aqua photoredox catalyst has been successfully heterogeneneized on graphene oxide (GO@trans-fac-) and graphite rods (GR@trans-fac-) for the first time and have proven to be sustainable and easily reusable...
10.
Munoz-Juan A, Nuez-Martinez M, Laromaine A, Vinas C
Chemistry
. 2023 Oct;
30(4):e202302484.
PMID: 37870209
Cobaltabis(dicarbollides), ferrabis(dicarbollide), and their halogenated derivatives are the most studied metallacarboranes with great medical potential. These versatile compounds and their iodinated derivatives can be used in chemotherapy, radiotherapy, particle therapy,...